Matches in Nanopublications for { ?s ?p "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP600261.RACEcNqOuXI2Z0OdBZOQOvtTTJ_tf4QRFDVdOCqHWua6E130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600261.RACEcNqOuXI2Z0OdBZOQOvtTTJ_tf4QRFDVdOCqHWua6E130_provenance.
- NP713979.RAf21Sl-AFQlbj15hBLjboDxVNUTr3gaHozqMdqjC33i4130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713979.RAf21Sl-AFQlbj15hBLjboDxVNUTr3gaHozqMdqjC33i4130_provenance.
- NP697059.RAvhdzO8wj595QvZdyMydTe7g8JrpdRsIrkMY3OXeoe50130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697059.RAvhdzO8wj595QvZdyMydTe7g8JrpdRsIrkMY3OXeoe50130_provenance.
- NP779907.RA2b5sDdpIx7vuIhe_hlcRWiO8IDHGN6f6rMEdTxFK7y8130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779907.RA2b5sDdpIx7vuIhe_hlcRWiO8IDHGN6f6rMEdTxFK7y8130_provenance.
- NP782351.RA6XPEm5k_iUrajdd7W_F162SYqmDN1uDhwbyFWcl_JtA130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782351.RA6XPEm5k_iUrajdd7W_F162SYqmDN1uDhwbyFWcl_JtA130_provenance.